pharmaceuticals

Leal Therapeutics is developing first-in-class therapeutics to correct metabolic imbalances in the brain for treatment of high unmet…

An avid consumer of dietary supplements, Health and Human Services Secretary Robert F. Kennedy Jr. has surrounded himself…

A sign with the company logo sits outside of the headquarters of Eli Lilly in Indianapolis, Indiana, on March…

The brain controls the release of glucose in a wide range of stressful circumstances, including fasting and low…

Rafael Henrique | SOPA Images | AP The U.S. health regulator has allowed a study of Rocket Pharmaceuticals’…

Ozempic® is the GLP-1 with the most FDA-approved uses for patients with type 2 diabetes including, improvement of…

First Breakthrough Therapy Designation in the U.S. for SystImmune and Bristol Myers Squibb’s Izalontamab brengitecan (Iza-bren) based on data…

Lawmakers say middlemen in the prescription drug pipeline are limiting access to medications and driving up costs.See the…

Published on 17/08/2025 – 9:30 GMT+2 ADVERTISEMENT Wealthy countries may pay steep prices for medicines, but once their…

Zheng-Yi Chen, DPhil, associate scientist at the Eaton-Peabody Laboratories, and Ines and Fredrick Yeatts Chair in Otolaryngology, at…

Mounjaro manufactured by Eli Lilly and Company packaging is seen in this illustration photo taken in a pharmacy…

A take-at-home tablet could boost the way cancer patients respond to chemotherapy, according to the medical experts who…

Leal Therapeutics Announces $30 Million Series A to Progress First-In-Class Neuro-Metabolic Therapies for Neurodegenerative and Neuropsychiatric Disorders with High-Unmet Need